JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 2


Figure 2 Fluorescein isothiocyanate (FITC)-fibrinogen binding (mean fluorescence units ± SEM) with adenosine diphosphate (ADP) in study subjects by treatment strategy. Significant differences under different conditions of blockade were noted (p < 0.01). Multiple comparisons (six included in adjustment per plot) at each agonist’s concentrations revealed significant differences (p < 0.05) between treatment strategies as indicated. *Applies for differences between treatment with acetylsalicylic acid (ASA) and with clopidogrel. {ddagger}Applies for differences treatment with acetylsalicylic acid (ASA) and with ASA plus clopidogrel in combination.





Right arrow Return to article


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK